LIPITOR TABLET 80 mg

国家: 新加坡

语言: 英文

来源: HSA (Health Sciences Authority)

现在购买

下载 资料单张 (PIL)
25-07-2014

有效成分:

ATORVASTATIN CALCIUM 86.80mg EQV ATORVASTATIN

可用日期:

PFIZER PRIVATE LIMITED

ATC代码:

C10AA05

剂量:

80 mg

药物剂型:

TABLET, FILM COATED

给药途径:

ORAL

处方类型:

Prescription Only

厂商:

PFIZER PHARMACEUTICALS LIMITED (VEGA BAJA)

授权日期:

2002-06-24

资料单张

                                  
Page 1 of 20 
 
LIPITOR
®
 TABLETS 
ATORVASTATIN CALCIUM 
 
 
 
1.   TRADE NAME(S) OF THE MEDICINAL PRODUCT 
 
LIPITOR 
 
 
2.   QUALITATIVE AND QUANTITATIVE COMPOSITION 
 
Active Ingredient: atorvastatin. 
 
The tablets for oral administration contain atorvastatin calcium equivalent to 10,
20, 40, or 80 mg 
atorvastatin. 
 
 
3.   PHARMACEUTICAL FORM 
 
Tablets: 10 mg, 20 mg, 40 mg, 80 mg. 
 
 
4.   CLINICAL PARTICULARS 
 
4.1  THERAPEUTIC INDICATIONS 
 
Atorvastatin is indicated as an adjunct to diet for reduction
of elevated total cholesterol 
(total-C), LDL-cholesterol (LDL-C), apolipoprotein B, and
triglycerides in adults, 
adolescents and children aged 10 years or older with
primary hypercholesterolemia, 
heterozygous familial hypercholesterolemia, or combined
(mixed) hyperlipidemia 
(Fredrickson Types IIa and IIb), elevated serum triglyceride levels
(Fredrickson Type IV), 
and for patients with dysbetalipoproteinemia (Fredrickson Type
III) when response to diet 
and other non-pharmacological measures is inadequate. 
 
Atorvastatin also raises HDL-cholesterol and lowers the LDL/HDL and
total 
cholesterol/HDL ratios. 
 
Atorvastatin is also indicated to reduce total-C and LDL-C in
adults with homozygous 
familial hypercholesterolaemia as an adjunct to
other lipid-lowering treatments (e.g., LDL 
apheresis) or if such treatments are unavailable. 
 
_Prevention of Cardiovascular Disease_ 
 
Lipitor is indicated to reduce the risk of myocardial infarction
in adult hypertensive patients 
without clinically evident coronary heart disease,
but with at least three additional risk factors 
for coronary heart disease such as age  55 years, male sex,
smoking, left ventricular 
hypertrophy, other specified abnormalities on ECG,
microalbuminia or proteinuria, ratio of 
plasma total cholesterol to HDL-cholesterol  6, or premature
family history of coronary
                                
                                阅读完整的文件